Financhill
Sell
36

LOW Quote, Financials, Valuation and Earnings

Last price:
$225.67
Seasonality move :
3.4%
Day range:
$221.02 - $224.76
52-week range:
$211.80 - $287.01
Dividend yield:
2.03%
P/E ratio:
18.38x
P/S ratio:
1.52x
P/B ratio:
--
Volume:
2.6M
Avg. volume:
2.6M
1-year change:
-8.25%
Market cap:
$125.7B
Revenue:
$83.7B
EPS (TTM):
$12.21
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Revenue $89.6B $96.3B $97.1B $86.4B $83.7B
Revenue Growth (YoY) 24.19% 7.43% 0.84% -11.01% -3.13%
 
Cost of Revenues $60B $64.2B $64.8B $57.5B $55.8B
Gross Profit $29.6B $32.1B $32.3B $28.8B $27.9B
Gross Profit Margin 33.01% 33.31% 33.23% 33.39% 33.32%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $18.5B $18.3B $20.3B $15.6B $15.7B
Other Inc / (Exp) -$1.1B -- -- -- --
Operating Expenses $19.9B $20B $22.1B $17.3B $17.4B
Operating Income $9.6B $12.1B $10.2B $11.6B $10.5B
 
Net Interest Expenses $848M $885M $1.1B $1.4B $1.3B
EBT. Incl. Unusual Items $7.7B $11.2B $9B $10.2B $9.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.9B $2.8B $2.6B $2.4B $2.2B
Net Income to Company $5.8B $8.4B $6.4B $7.7B $7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5.8B $8.4B $6.4B $7.7B $7B
 
Basic EPS (Cont. Ops) $7.77 $12.07 $10.20 $13.23 $12.25
Diluted EPS (Cont. Ops) $7.75 $12.04 $10.17 $13.20 $12.23
Weighted Average Basic Share $748M $696M $629M $582M $567M
Weighted Average Diluted Share $750M $699M $631M $584M $568M
 
EBITDA $10.2B $14B $12.2B $13.6B $12.4B
EBIT $8.6B $12.1B $10.2B $11.7B $10.5B
 
Revenue (Reported) $89.6B $96.3B $97.1B $86.4B $83.7B
Operating Income (Reported) $9.6B $12.1B $10.2B $11.6B $10.5B
Operating Income (Adjusted) $8.6B $12.1B $10.2B $11.7B $10.5B
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Revenue $20.3B $21.3B $22.4B $18.6B $18.6B
Revenue Growth (YoY) 26.73% 5.06% 5.18% -17.12% -0.26%
 
Cost of Revenues $13.9B $14.3B $15.2B $12.6B $12.5B
Gross Profit $6.5B $7B $7.3B $6B $6.1B
Gross Profit Margin 31.79% 32.93% 32.33% 32.4% 32.86%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.5B $4.7B $5.1B $3.9B $3.8B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $4.9B $5.2B $5.6B $4.3B $4.3B
Operating Income $1.5B $1.8B $1.7B $1.7B $1.8B
 
Net Interest Expenses $204M $235M $321M $349M $328M
EBT. Incl. Unusual Items $1.3B $1.6B $1.4B $1.3B $1.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $342M $407M $425M $319M $377M
Net Income to Company $978M $1.2B $958M $1B $1.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $978M $1.2B $958M $1B $1.1B
 
Basic EPS (Cont. Ops) $1.33 $1.79 $1.58 $1.77 $2.00
Diluted EPS (Cont. Ops) $1.32 $1.78 $1.58 $1.77 $1.99
Weighted Average Basic Share $733M $672M $602M $573M $562M
Weighted Average Diluted Share $738M $684M $604M $575M $563M
 
EBITDA $2B $2.3B $2.2B $2.2B $2.3B
EBIT $1.5B $1.9B $1.7B $1.7B $1.8B
 
Revenue (Reported) $20.3B $21.3B $22.4B $18.6B $18.6B
Operating Income (Reported) $1.5B $1.8B $1.7B $1.7B $1.8B
Operating Income (Adjusted) $1.5B $1.9B $1.7B $1.7B $1.8B
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Revenue $89.6B $96.2B $97.1B $86.4B $83.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $60B $64.2B $64.8B $57.5B $55.8B
Gross Profit $29.6B $32.1B $32.3B $28.8B $27.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $18.5B $18.3B $20.3B $15.6B $15.7B
Other Inc / (Exp) -$1.1B -- -- -- --
Operating Expenses $19.9B $20B $22.1B $17.3B $17.4B
Operating Income $9.6B $12.1B $10.2B $11.6B $10.5B
 
Net Interest Expenses $849M $885M $1.1B $1.4B $1.3B
EBT. Incl. Unusual Items $7.7B $11.2B $9B $10.2B $9.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.9B $2.8B $2.6B $2.4B $2.2B
Net Income to Company $5.8B $8.4B $6.4B $7.7B $7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5.8B $8.4B $6.4B $7.7B $7B
 
Basic EPS (Cont. Ops) $7.75 $12.02 $10.03 $13.18 $12.23
Diluted EPS (Cont. Ops) $7.73 $11.97 $10.01 $13.16 $12.21
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $10.2B $14B $12.2B $13.6B $12.6B
EBIT $8.6B $12.1B $10.2B $11.7B $10.6B
 
Revenue (Reported) $89.6B $96.2B $97.1B $86.4B $83.7B
Operating Income (Reported) $9.6B $12.1B $10.2B $11.6B $10.5B
Operating Income (Adjusted) $8.6B $12.1B $10.2B $11.7B $10.6B
Period Ending 2022-01-31 2023-01-31 2024-01-31 2025-01-31 2026-01-31
Revenue $96.2B $97.1B $86.3B $83.7B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $64.2B $64.8B $57.5B $55.8B --
Gross Profit $32.1B $32.3B $28.8B $27.9B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $18.3B $20.3B $15.6B $15.7B --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $20B $22.1B $17.3B $17.4B --
Operating Income $12.1B $10.2B $11.6B $10.5B --
 
Net Interest Expenses $885M $1.1B $1.4B $1.3B --
EBT. Incl. Unusual Items $11.2B $9B $10.2B $9.2B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.8B $2.6B $2.4B $2.2B --
Net Income to Company $8.4B $6.4B $7.7B $7B --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $8.4B $6.4B $7.7B $7B --
 
Basic EPS (Cont. Ops) $12.02 $10.03 $13.18 $12.23 --
Diluted EPS (Cont. Ops) $11.97 $10.01 $13.16 $12.21 --
Weighted Average Basic Share $2.8B $2.5B $2.3B $2.3B --
Weighted Average Diluted Share $2.8B $2.5B $2.3B $2.3B --
 
EBITDA $14B $12.2B $13.6B $12.6B --
EBIT $12.1B $10.2B $11.7B $10.6B --
 
Revenue (Reported) $96.2B $97.1B $86.3B $83.7B --
Operating Income (Reported) $12.1B $10.2B $11.6B $10.5B --
Operating Income (Adjusted) $12.1B $10.2B $11.7B $10.6B --
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Cash and Equivalents $4.7B $1.1B $1.3B $921M $1.8B
Short Term Investments -- -- -- -- $372M
Accounts Receivable, Net -- -- -- -- --
Inventory $16.2B $17.6B $18.5B $16.9B $17.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $937M $1.1B $1.2B $949M $816M
Total Current Assets $22.3B $20.1B $21.4B $19.1B $20.4B
 
Property Plant And Equipment $23B $23.2B $21.1B $21.4B $21.4B
Long-Term Investments -- -- $21M -- $277M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.1B $1.2B $910M $1.1B $836M
Total Assets $46.7B $44.6B $43.7B $41.8B $43.1B
 
Accounts Payable $10.9B $11.4B $10.5B $8.7B $9.3B
Accrued Expenses $250M $275M $441M $456M --
Current Portion Of Long-Term Debt $1.1B $868M $585M $537M $2.6B
Current Portion Of Capital Lease Obligations $541M $636M $522M $487M $563M
Other Current Liabilities $1.7B $1.8B $1.7B $1.9B $4B
Total Current Liabilities $18.7B $19.7B $19.5B $15.6B $18.8B
 
Long-Term Debt $20.7B $23.9B $32.9B $35.4B $32.9B
Capital Leases -- -- -- -- --
Total Liabilities $45.3B $49.5B $58B $56.8B $57.3B
 
Common Stock $366M $335M $301M $287M $280M
Other Common Equity Adj -$136M -$36M $307M $300M $288M
Common Equity $1.4B -$4.8B -$14.3B -$15.1B -$14.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.4B -$4.8B -$14.3B -$15.1B -$14.2B
 
Total Liabilities and Equity $46.7B $44.6B $43.7B $41.8B $43.1B
Cash and Short Terms $4.7B $1.1B $1.3B $921M $2.1B
Total Debt $21.8B $24.7B $34B $35.9B $35.5B
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Cash and Equivalents $4.7B $1.1B $1.3B $921M $1.8B
Short Term Investments -- -- -- -- $372M
Accounts Receivable, Net -- -- -- -- --
Inventory $16.2B $17.6B $18.5B $16.9B $17.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $937M $1.1B $1.2B $949M $816M
Total Current Assets $22.3B $20.1B $21.4B $19.1B $20.4B
 
Property Plant And Equipment $23B $23.2B $21.1B $21.4B $21.4B
Long-Term Investments -- -- $21M -- $277M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.1B $1.2B $910M $1.1B $836M
Total Assets $46.7B $44.6B $43.7B $41.8B $43.1B
 
Accounts Payable $10.9B $11.4B $10.5B $8.7B $9.3B
Accrued Expenses $250M $275M $441M $456M --
Current Portion Of Long-Term Debt $1.1B $868M $585M $537M $2.6B
Current Portion Of Capital Lease Obligations $541M $636M $522M $487M $563M
Other Current Liabilities $1.7B $1.8B $1.7B $1.9B $4B
Total Current Liabilities $18.7B $19.7B $19.5B $15.6B $18.8B
 
Long-Term Debt $20.7B $23.9B $32.9B $35.4B $32.9B
Capital Leases -- -- -- -- --
Total Liabilities $45.3B $49.5B $58B $56.8B $57.3B
 
Common Stock $366M $335M $301M $287M $280M
Other Common Equity Adj -$136M -$36M $307M $300M $288M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.4B -$4.8B -$14.3B -$15.1B -$14.2B
 
Total Liabilities and Equity $46.7B $44.6B $43.7B $41.8B $43.1B
Cash and Short Terms $4.7B $1.1B $1.3B $921M $2.1B
Total Debt $21.8B $24.7B $34B $35.9B $35.5B
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Net Income to Stockholders $5.8B $8.4B $6.4B $7.7B $7B
Depreciation & Amoritzation $1.6B $1.9B $2B $1.9B $2B
Stock-Based Compensation $155M $230M $223M $210M $221M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$3B -$1.4B -$2.6B $1.6B -$514M
Cash From Operations $11B $10.1B $8.6B $8.1B $9.6B
 
Capital Expenditures $1.8B $1.9B $1.8B $2B $1.9B
Cash Acquisitions -- -- $491M $100M $177M
Cash From Investing -$1.9B -$1.6B -$1.3B -$1.9B -$1.7B
 
Dividends Paid (Ex Special Dividend) -$1.7B -$2B -$2.4B -$2.5B -$2.6B
Special Dividend Paid
Long-Term Debt Issued $7.9B $5B $9.7B $3B --
Long-Term Debt Repaid -$5.6B -$2.1B -$867M -$601M -$545M
Repurchase of Common Stock -$5B -$13B -$14.1B -$6.1B -$4.1B
Other Financing Activities -$38M -$6M -$5M -$21M -$42M
Cash From Financing -$5.2B -$12B -$7B -$6.7B -$7B
 
Beginning Cash (CF) $716M $4.7B $1.1B $1.3B $921M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4B -$3.5B $231M -$427M $840M
Ending Cash (CF) $4.7B $1.1B $1.3B $921M $1.8B
 
Levered Free Cash Flow $9.3B $8.3B $6.8B $6.2B $7.7B
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Net Income to Stockholders $978M $1.2B $958M $1B $1.1B
Depreciation & Amoritzation $442M $494M $472M $496M $511M
Stock-Based Compensation $48M $61M $58M $50M $57M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$422M -$967M -$286M $635M $158M
Cash From Operations -$436M $934M $451M $1.1B $911M
 
Capital Expenditures $619M $597M $739M $620M $548M
Cash Acquisitions -- -- $491M -- $80M
Cash From Investing $758M -$286M -$194M -$595M -$418M
 
Dividends Paid (Ex Special Dividend) -$452M -$551M -$643M -$632M -$650M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$36M -$1.5B -$36M -$25M -$23M
Repurchase of Common Stock -$3.4B -$4B -$2B -$201M -$1.4B
Other Financing Activities -$6M $402M -$5M -$6M -$22M
Cash From Financing -$3.9B -$5.6B -$2.1B -$802M -$2B
 
Beginning Cash (CF) $8.2B $6.1B $3.2B $1.2B $3.3B
Foreign Exchange Rate Adjustment $6M -$11M $16M -- --
Additions / Reductions -$3.6B -$5B -$1.9B -$289M -$1.5B
Ending Cash (CF) $4.7B $1.1B $1.3B $921M $1.8B
 
Levered Free Cash Flow -$1.1B $337M -$288M $488M $363M
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Net Income to Stockholders $5.8B $8.4B $6.4B $7.7B $7B
Depreciation & Amoritzation $1.6B $1.9B $2B $1.9B $2B
Stock-Based Compensation $155M $230M $223M $210M $221M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$3B -$1.4B -$2.6B $1.6B -$514M
Cash From Operations $11B $10.1B $8.6B $8.1B $9.6B
 
Capital Expenditures $1.8B $1.9B $1.8B $2B $1.9B
Cash Acquisitions -- -- $491M $100M $177M
Cash From Investing -$1.9B -$1.6B -$1.3B -$1.9B -$1.7B
 
Dividends Paid (Ex Special Dividend) -$1.7B -$2B -$2.4B -$2.5B -$2.6B
Special Dividend Paid
Long-Term Debt Issued $7.9B $5B $9.7B $3B --
Long-Term Debt Repaid -$5.6B -$2.1B -$867M -$601M -$545M
Repurchase of Common Stock -$5B -$13B -$14.1B -$6.1B -$4.1B
Other Financing Activities -$38M -$6M -$5M -- -$42M
Cash From Financing -$5.2B -$12B -$7B -$6.7B -$7B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4B -$3.5B $231M -$427M $840M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $9.3B $8.3B $6.8B $6.2B $7.7B
Period Ending 2022-01-31 2023-01-31 2024-01-31 2025-01-31 2026-01-31
Net Income to Stockholders $8.4B $6.4B $7.7B $7B --
Depreciation & Amoritzation $1.9B $2B $1.9B $2B --
Stock-Based Compensation $230M $223M $210M $221M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$1.4B -$2.6B $1.6B -$514M --
Cash From Operations $10.1B $8.6B $8.1B $9.6B --
 
Capital Expenditures $1.9B $1.8B $2B $1.9B --
Cash Acquisitions -- $491M $100M $177M --
Cash From Investing -$1.6B -$1.3B -$1.9B -$1.7B --
 
Dividends Paid (Ex Special Dividend) -$2B -$2.4B -$2.5B -$2.6B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $5B $9.7B $3B -- --
Long-Term Debt Repaid -$2.1B -$867M -$601M -$545M --
Repurchase of Common Stock -$13B -$14.1B -$6.1B -$4.1B --
Other Financing Activities -$6M -$5M -$21M -$42M --
Cash From Financing -$12B -$7B -$6.7B -$7B --
 
Beginning Cash (CF) $22.3B $9.2B $9B $11.8B --
Foreign Exchange Rate Adjustment -$8M -$16M -- -- --
Additions / Reductions -$3.5B $231M -$427M $840M --
Ending Cash (CF) $18.8B $9.4B $8.6B $12.6B --
 
Levered Free Cash Flow $8.3B $6.8B $6.2B $7.7B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Is Ford Stock Undervalued Amid the EV Transition?
Is Ford Stock Undervalued Amid the EV Transition?

There is a lot going on in the electric vehicle…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
49
SMTC alert for Mar 17

Semtech [SMTC] is down 0.49% over the past day.

Buy
62
PLPC alert for Mar 17

Preformed Line Products [PLPC] is up 3.8% over the past day.

Sell
50
NUTX alert for Mar 17

Nutex Health [NUTX] is up 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock